Dr. Peng Geng | Nanomaterials | Best Researcher Award

Professor at China Three Gorges University, China

Dr. Peng Geng is a distinguished researcher and academic in the field of nanomaterials-based biomedical engineering, currently serving as a Lecturer at the College of Material and Chemical Engineering, China Three Gorges University. With a doctorate in Materials Science, his work spans advanced therapeutic applications including photothermal, photodynamic, sonodynamic, and chemodynamic therapy, alongside bioimaging innovation. He has earned recognition in high-impact journals and plays a pivotal role in the development of interdisciplinary strategies to combat complex medical challenges.

Profile

ORCID

Education

Dr. Geng pursued his doctoral studies at Donghua University, completing his Ph.D. in Materials Science in 2022. During his time there, he gained strong expertise in nanoparticle design and functionalization for therapeutic applications. His academic foundation blends materials science, chemistry, and biomedical engineering, equipping him with a versatile skill set to address emerging health-related technologies.

Experience

Following his doctoral completion, Dr. Geng joined China Three Gorges University as a Lecturer in the College of Material and Chemical Engineering. In this capacity, he has been instrumental in supervising advanced research projects and mentoring students in nanoparticle-based therapy design. His collaborative efforts span multidisciplinary teams and include international co-authors, reflecting a global perspective on research and innovation.

Research Interest

Dr. Geng’s research interests converge at the interface of materials science and biomedical applications. He focuses on engineering multifunctional nanoparticles tailored for cutting-edge therapeutic interventions such as photothermal therapy, photodynamic therapy, chemodynamic therapy, sonodynamic therapy, and real-time bioimaging. His work addresses challenges in drug delivery efficiency, precision targeting, and synergistic treatment approaches, all geared toward improving clinical outcomes in oncology and diagnostics.

Awards

Dr. Geng’s contributions have earned significant acclaim, including the publication of an article in the Chemical Engineering Journal (2022), which was recognized as an ESI Highly Cited Paper. This acknowledgment reflects the high impact and relevance of his work in the scientific community and highlights his growing influence in the field of nanomedicine.

Publications

Dr. Geng has published extensively in leading journals in his field. Notable examples include:

1. Geng P. et al., “Nanocomposites for Synergistic Photothermal and Chemodynamic Therapy,” Advanced Healthcare Materials, 2021.
2. Geng P. et al., “Smart Nanoplatforms for Tumor Microenvironment-Responsive Therapy,” ACS Applied Materials & Interfaces, 2021.
3. Liu X.H., Geng P. et al., “Nanomaterials for Antitumor Activity via Reactive Oxygen Species,” Journal of Colloid and Interface Science, 2022.
4. Geng P. et al., “Multimodal Nanoplatforms for Imaging-Guided Therapy,” Chemical Engineering Journal, 2022 – ESI Highly Cited Article.
5. Geng P. et al., “New Dyes for Tumor Phototherapy Applications,” Dyes and Pigments, 2023.
6. Geng P. et al., “Interface Modulation of Photothermal Agents,” Journal of Colloid and Interface Science, 2024.
7. Geng P. et al., “Functional Nanomaterials for Targeted Drug Delivery,” Acta Chimica Sinica, 2024.

These contributions have collectively advanced the field of nanoparticle-based therapeutic technologies and are frequently cited by researchers across disciplines. Single-line prompt: Dr. Geng’s work on multifunctional nanoplatforms for cancer therapy is widely cited and highly regarded in the scientific community.

Conclusion

Through his innovative research and academic dedication, Dr. Peng Geng has emerged as a rising leader in the integration of material science and biomedical applications. His work not only provides novel treatment solutions but also paves the way for translational technologies that bridge laboratory research and clinical practice. His growing portfolio of publications and collaborations makes him a compelling nominee for recognition in scientific excellence and societal impact.